Retatrutide CAS 2381089-83-2 LY3437943 Peptide Powder 99% Purity Research Use Only
TDS 7503 Inquiries
2381089-83-2
Pharmaceutical Grade
99%
shenzhen
No Brand
10mg/20mg/30mg/40mg/50mg/60mg
2026-11-26
Peptides,Tirzepatide,Retatrutide,GLP-1,Semaglutide,AMK-CU
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionProduct Description
RetatrutideRetatrutide 10MG-60MG
RetatrutideDifferent capacity
RetatrutideGiving you a different experience, more vibrant.
Product Name Retatrutide Powder Iype Lyophilized Powder storage Store in a cool and dark place Specific 5mg/10mg/15mg/20mg/30mg/40mg/60mg /1g INTRODUCEThis catalog introduces available research-grade peptides and related bioactive molecules, covering research fields including skin and tissue repair, anti-inflammation, metabolic regulation, mitochondrial function and antioxidation.
These products are synthesized via Solid-Phase Peptide Synthesis (SPPS) technology, purified by High Performance Liquid Chromatography (HPLC) and characterized by Mass Spectrometry (MS).
They are supplied as high-purity lyophilized powder. A Certificate of Analysis (COA) is provided for each batch, with full batch traceability.
1.Specifications & StorageOur research peptides are available in multiple packaging specifications ranging from milligram to gram scale, to meet diverse laboratory research demands.For long-term preservation, store lyophilized peptides at -20°C under dry and dark conditions. Avoid repeated freeze-thaw cycles to prevent peptide degradation after reconstitution.2.Custom Peptide Synthesis ServiceWe offer custom peptide synthesis services, including sequence design, peptide modification such as acetylation, amidation, fluorescent labeling and biotin labeling.
Custom products can be produced according to your requested purity level and quantity, suitable for custom cell assays and preclinical animal studies.3.Sample & DeliverySmall quantity samples are available for preliminary lab validation.Standard lead time varies based on peptide length and modification complexity. We use cold-chain packaging for sensitive peptide products to guarantee quality during transit.
4.Quality ControlEach batch undergoes strict quality control tests including HPLC purity detection, MS molecular weight verification, water content and residual solvent test.All testing records are archived, enabling complete batch traceability for your research documentation.Reasons to Choose Our Retatrutide
1.High-quality Retatrutide manufactured via mature SPPS solid-phase peptide synthesis technology. Each batch is verified by HPLC and MS to guarantee high purity.
2.Complete batch traceability. COA certificate will be provided together with shipment for every batch of Retatrutide to support your research documentation.。
3.Available in multiple packaging scales, including mg-level lab samples and bulk raw material, supporting both preliminary research and large-scale experimental use.
4.Strict cold-chain packaging for lyophilized peptide, effectively avoiding peptide degradation during international transportation.
5.Professional technical support for research-grade peptides. Our team can assist with storage guidance and general technical inquiries for your lab projects.
6.Flexible order schedule and stable supply capacity, reliable long-term supplier for your continuous scientific research projects.
If you choose us, you will be our valued partner. We will provide you with premium services. We offer timely technical consultation and quick responses to your inquiries. We can arrange sample evaluation and update production progress regularly for your reference. All requested documents including TDS, COA and MSDS will be prepared and delivered along with your shipment. We maintain flexible communication to solve any technical or logistics issues encountered during cooperation.We adopt strict quality control procedures for every batch of Retatrutide. We will keep you informed promptly once the production and testing are finished.CHAT MY WhatsApp+85256110626ECHEMI Editorial ReferenceRetatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.CertificatesBasic Info-
Product Name:
Retatrutide
Other Name:Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide
CAS No.:2381089-83-2
InChIKeys:MLOLQJNKXBNWFW-SAGGEDDASA-N
Molecular Weight:0
EC Number:200-001-8
Color/Form:White lyophilized
Categories:
Characteristics-
Water Solubility:
Soluble in water (5mg/ml).
Storage Conditions:-20°C
Critical Temperature & Pressure:-20°C
Research-
Class:
Triple agonist — GCGR, GIPR, GLP-1R
Status:Investigational (Phase 3)
Mechanism:Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.
EC50 (Human GCGR):5.79 nM
EC50 (Mouse GIPR):0.191 nM
EC50 (Mouse GLP1R):0.794 nM
EC50 (Mouse GCGR):2.32 nM
EC50 (Human GLP1R):0.775 nM
EC50 (Human GIPR):0.0643 nM
Source:Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI
Clinical Development:
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptides,Tirzepatide,Retatrutide,GLP-1,Semaglutide,AMK-CU
-
Location:
18 Linchang, Wujin district, Changzhou, China
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
-
-
Inquiry History7503 Inquiries
Country Product Purchase Quantity Date Posted
Malaysia
Retatrutide
20 MG Oct 28, 2026
Brazil
Retatrutide
10 Oct 29, 2026
Australia
Retaturtide
100 MG Oct 29, 2026
United States
Retatrutide 30mg and 50mg
20 PCS Oct 29, 2026
Belgium
Retatrutide
1 MG Oct 29, 2026
Romania
Retatrutide
10 G Oct 29, 2026
United States
Retatrutide
2 MT Oct 29, 2026
United States
Retatrutide
1 MT Oct 29, 2026
United Kingdom
Retatrutide
1 PCS Oct 28, 2026
United States
Retatrutide
30 MT Oct 28, 2026
United Kingdom
Retatrutide
10 MT Oct 28, 2026
United States
retatrutide
30 MG Oct 28, 2026
Czech
Retatrutide
10 MG Oct 28, 2026
Austria
retatrutide
30 MG Oct 28, 2026
United States
Retatrutide
100 KG Oct 28, 2026
Malta
Retatrutide
10 MT Oct 28, 2026
United States
Retatrutide
600 MG Oct 28, 2026
United States
Retatrutide
500 G Oct 28, 2026
United States
Retatrutide
60 G Oct 28, 2026
Croatia
Retatrutide
10 MG Oct 28, 2026 Post an enquiry for this product
More from this Seller
-
-
-
Melanotan 2, MT2, melanocortin agonist, tanning peptide, research peptide
Pharmaceutical Grade / 99%
$8-9/G FOB
-
-
-
-
SLU-PP-332 Boost metabolism Reduce fat accumulation Increase muscle mass
Pharmaceutical Grade / 99%
$7/G FOB
-
-
-
-
NAD+ Nicotinamide Adenine Dinucleotide Raw Compound White Powder
Pharmaceutical Grade / 99%
$130-150/UNIT FOB
-
-
-
-
AHK-CU50 Freeze Dried Peptide Powder Synthetic Raw Material For Academic Biochemical Research Test
Pharmaceutical Grade / 99%
$25-30/UNIT FOB
-
-
-
-
Adipotide Preserves lean muscle mass during fat reduction Achieves rapid weight loss
Pharmaceutical Grade / 99%
$8-9/G FOB
-
-
-
-
KPV White to off-white lyophilized loose powder Anti-inflammation Relieve red and sensitive skin, improve inflammatory acne
Pharmaceutical Grade / 99%
$11-12/G FOB
-
